NeOnc Technologies Holdings is trading 11.75% up in pre-market at $2.90, versus the October 13 close of $2.60; the reason remains unclear. - No company-specific catalyst for October 14 was confirmed; the press-release page lists September 28 as its latest release. - That release announced a November 17 FDA meeting concerning NEO212, predating the move. Market context was mixed, and the supplied report noted after-hours strength; no verified October 14 news or trading-volume data was identified.